Radiofrequency ablation for primary lung cancer and pulmonary metastases

Clinical Lung Cancer

Volumn 9, Issue 1, 2008, Pages 16-23

  White, David C ^a   D'Amico, Thomas A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Non small cell carcinoma; Pneumothorax; Positron emission tomography; Radiation therapy

Indexed keywords

CANCER GROWTH; CANCER SURVIVAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; LUNG CANCER; LUNG METASTASIS; LUNG SMALL CELL CANCER; MORBIDITY; MORTALITY; NECROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMOTHORAX; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; REVIEW;

EID: 39149088653     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2008.n.003     Document Type: Review

References (49)

1. American Cancer Society. Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society; 2007.
2. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-7.
3. McKenna RJ Jr, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006; 81:421-5.
4. Onaitis MW, Petersen RP, Balderson SS, et al. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 2006; 244:420-5.
5. Qiao X, Tullgren O, Lax I, et al. The role of radiothetapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003; 41:1-11.
6. Gazelle GS, Goldberg SN, Solbiati L, et al. Tumor ablation with radio-frequency energy. Radiology 2000; 217:633-46.
7. McGahan JP, Brock JN, Tessluk H, et al. Hepatic ablation with use of radiofrequency electrocautery in the animal model. J Vasc Interv Radiol 1992; 3:291-7.
8. Goldberg SN, Gazelle GS, Dawson SL, et al. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1995; 2:399-404.
9. Ahmed M, Liu Z, Afzal KS, et al. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 2004; 230:761-7.
10. Goldberg SN, Gazelle GS. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 1995; 2:776-84.
11. Goldberg SN, Gazelle FS, Compton CC, et al. Radiofrequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol 1996; 3:929-35.
12. Tanigawa N, Sawada S, Okuda Y, et al. Percutaneous radiofrequency thermal coagulation therapy for lung tumors: an experimental study. Jpn J Intervent Radiol 1997; 12:58-62.
13. LeVeen RF. Laser hyperthermia and radiofrequency ablation of hepatic lesions. Semin Interv Radiol 1997; 14:313-24.
14. Livraghi T, Goldberg SN, Monti F, et al. Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202:205-10.
15. Lee JM, Han JK, Chang JM, et al. Radiofrequency ablation in pig lungs: in vivo comparison of internally cooled, perfusion and multitined expandable electrodes. Br J Radiol 2006; 79:562-71.
16. Hiraki T, Sakurai J, Tsuda T, et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors. Cancer 2006; 107:2873-80.
17. Hughes KS, Simon R, Songhorabadi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988; 103:278-84.
18. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938-46.
19. Rossi S, DiStasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167:759-68.
20. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997; 202:195-203.
21. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Ann Surg 1999; 230:1-8.
22. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221:159-66.
23. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997; 113:37-49.
24. Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174:57-9.
25. Nishida T, Inoue K, Kawata Y, et al. Percutaneous radiofrequency ablation of lung neoplasms: a minimally invasive strategy for inoperable patients. J Am Coll Surg 2002; 195:426-30.
26. Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg 2003; 125:929-37.
27. Suh RD, Wallace AB, Sheehan RE, et al. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results. Radiology 2003; 229:821-9.
28. Steinke K, Glenn D, King J, et al. Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 2004; 11:207-12.
29. Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004; 230:125-34.
30. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 2004; 231:850-7.
31. Gadaleta C, Mattioli V, Colucci G, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol 2004; 183:361-8.
32. Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer-a preliminary report of 33 patients. AJR Am J Roentgenol 2004; 183:1003-11.
33. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004; 15:463-70.
34. Kang S, Luo R, Liao W, et al. Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment positron emission tomography in lung tumors. World J Surg Oncol 2004; 2:30.
35. VanSonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience - technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 2005; 184:381-90.
36. Fernando HC, De Hoyos A, Landreneau R, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005; 129:639-44.
37. Hoffman RT, Jakobs TF, Lubienski A, et al. Percutaneous radiofrequency ablation of pulmonary tumors - Is there a difference between treatment under general anaesthesia and under conscious sedation? Eur J Radiol 2006; 59:168-74.
38. Hiraki T, Sakurai J, Tsuda T, et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors. Cancer 2006; 107:2873-80.
39. Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies. Cancer 2007; 109:1397-405.
40. Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumors: results in the mid-term. Eur J Cardiothoracic Surg 2006; 30:177-83.
41. Ambrogi MC, Fontanini G, Cioni R, et al. Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study. J Thorac Cardiovasc Surg 2006; 131:1002-6.
42. Yan TD, King J, Sjarif A, et al. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determiants for survival. Ann Surg Oncol 2006; 13:1529-37.
43. Yan TD, King J, Sjarif A, et al. Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma. Ann Surg Oncol 2007; 14:1718-26.
44. de Baère T, Palussiere J, Auperin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 2006; 240:587-96.
45. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243:268-75.
46. Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 2007; 18:393-8.
47. Ambrogi MC, Dini P, Melfi F, et al. Radiofrequency ablation of inoperable non-small cell lung cancer. J Thorac Oncol 2007; 2(5 Suppl):2-3.
48. Vaughn C, Mychaskiw G II, Sewell P. Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm. Anesth Analg 2002; 94:1149-51.
49. Rose SC, Fotoohi M, Levin DL, et al. Cerebral microembolization during radiofrequency ablation of lung malignancies. J Vasc Interv Radiol 2002; 13:1051-4.